Joinn Laboratories(China)Co Market Cap ($4.11 Billion)
Market Cap & Net Worth: Joinn Laboratories(China)Co (603127)
Joinn Laboratories(China)Co market cap. Joinn Laboratories(China)Co (SHG:603127) has a market capitalization of $4.11 Billion (CN¥28.08 Billion) as of November 10, 2026. Listed on the SHG stock exchange, this China-based company holds position #3941 globally and #543 in its home market, demonstrating a -2.69% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Joinn Laboratories(China)Co's stock price CN¥44.55 by its total outstanding shares 630353014 (630.35 Million). Also see Joinn Laboratories(China)Co operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Joinn Laboratories(China)Co Market Cap History (2017–2026)
Joinn Laboratories(China)Co market cap history from 2017 to 2026. Data shows growth from $655.91 Million to $4.11 Billion (37.94% CAGR). Check 603127 stock price and chart for real-time trading data and today's change.
Joinn Laboratories(China)Co Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Joinn Laboratories(China)Co's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 603127 net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.95x
Joinn Laboratories(China)Co's market cap is 1.95 times its annual revenue
Latest Price to Earnings (P/E) Ratio
10.84x
Joinn Laboratories(China)Co's market cap is 10.84 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $655.91 Million | $301.28 Million | $76.45 Million | 2.18x | 8.58x |
| 2018 | $791.19 Million | $408.80 Million | $108.34 Million | 1.94x | 7.30x |
| 2019 | $1.35 Billion | $639.38 Million | $186.77 Million | 2.12x | 7.25x |
| 2020 | $3.39 Billion | $1.08 Billion | $315.01 Million | 3.15x | 10.77x |
| 2021 | $5.33 Billion | $1.52 Billion | $557.46 Million | 3.51x | 9.56x |
| 2022 | $3.79 Billion | $2.27 Billion | $1.07 Billion | 1.67x | 3.53x |
| 2023 | $2.19 Billion | $2.38 Billion | $396.99 Million | 0.92x | 5.51x |
| 2024 | $1.53 Billion | $2.02 Billion | $74.08 Million | 0.76x | 20.71x |
| 2025 | $3.23 Billion | $1.66 Billion | $297.84 Million | 1.95x | 10.84x |
Competitor Companies of 603127 by Market Capitalization
Companies near Joinn Laboratories(China)Co in the global market cap rankings as of November 10, 2026. Also see Joinn Laboratories(China)Co asset portfolio for a full breakdown of the balance sheet.
Key companies related to Joinn Laboratories(China)Co by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #86 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #143 globally with a market cap of $162.64 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #505 globally with a market cap of $53.20 Billion USD ( CN¥363.57 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #596 globally with a market cap of $44.78 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #86 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $694.76 |
| #143 | Danaher Corporation | NYSE:DHR | $162.64 Billion | $230.25 |
| #505 | WuXi AppTec Co Ltd | SHG:603259 | $53.20 Billion | CN¥147.00 |
| #596 | Natera Inc | NASDAQ:NTRA | $44.78 Billion | $310.67 |
Market Capitalization of Joinn Laboratories(China)Co (2017–2026)
Market capitalization of Joinn Laboratories(China)Co from 2017 to today. Between 2017 and today, Joinn Laboratories(China)Co's market cap moved from $655.91 Million to $ 4.11 Billion, with a yearly change of 37.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥4.11 Billion | +27.25% |
| 2025 | CN¥3.23 Billion | +110.52% |
| 2024 | CN¥1.53 Billion | -29.86% |
| 2023 | CN¥2.19 Billion | -42.30% |
| 2022 | CN¥3.79 Billion | -28.86% |
| 2021 | CN¥5.33 Billion | +57.06% |
| 2020 | CN¥3.39 Billion | +150.67% |
| 2019 | CN¥1.35 Billion | +71.05% |
| 2018 | CN¥791.19 Million | +20.62% |
| 2017 | CN¥655.91 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 9th, 2026 the market cap of Joinn Laboratories(China)Co was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.11 Billion USD |
| MoneyControl | $4.11 Billion USD |
| MarketWatch | $4.11 Billion USD |
| marketcap.company | $4.11 Billion USD |
| Reuters | $4.11 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Joinn Laboratories(China)Co
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics… Read more